Add this event to your calendarApr 22, 2019 – Apr 23, 201904/23/20194th Annual Stanford Drug Discovery Symposium
Advances in research and technology now afford us the unique
opportunity to develop and test novel diagnostics and therapeutics.
This conference takes advantage of the collective experience and
expertise of its speakers in drug discovery. A broad range of policy,
research, and venture topics are covered.
Add this event to your calendarMay 1, 2019 10:00 AM05/01/2019Virus-Specific Target Capture Coupled with NGS for Rapid and Sensitive Respiratory Virus Detection
This webinar will discuss the benefits of virus-specific target
capture combined with next-generation sequencing (NGS) to identify
viral infections and conduct comprehensive genomic and transcriptomic interrogation.
The high diversity of inter-virus genome types and intra-virus
genomic heterogeneity, together with the complexity of sample types,
make NGS-based clinical virology difficult, arduous, and expensive. A
single method that is able to use nucleic acids that are of low
quantity and poor quality to examine both DNA and RNA viruses from a
mixed cell population that may include human, bacteria, and viruses
would be ideal.
To this end, our speaker, Darrell L. Dinwiddie of the University of
New Mexico Health Sciences Center, will discuss a method his team has
been evaluating that uses virus-specific target capture probe sets
coupled with NGS.
Dr. Dinwiddie will discuss how this method has demonstrated
significant improvement in respiratory viral identification and genome
coverage compared to unenriched NGS. His team has shown the ability to
effectively capture and sequence viruses that may differ from the
probes by as much as 10 percent to 15 percent. These methods have
worked for viral sequencing from purified viral stocks, in
vitro cell culture, and clinical samples.
This webinar will also address the broader implications of this
work, including surveillance, epidemiologic studies, and public health planning.
For example, in two hospital outbreak studies, Dr. Dinwiddie and
colleagues have shown that target capture and NGS enabled sensitive
discrimination of the relatedness of respiratory syncytial virus and
human parainfluenza virus 3 isolates obtained during the outbreak and
provided evidence for source of transmission.
addition, through multi-year retrospective and prospective NGS studies
of respiratory viral infections at multiple pediatric hospitals, Dr.
Dinwiddie and his team have been able to examine seasonal respiratory
virus genomic variation, evolution, and distribution for several
respiratory viruses. This includes evaluating the match of vaccine to
circulating influenza virus strains and the correlation between virus
strains and clinical severity of infections. The recently developed
Human Pan Viral sequencing methods by Illumina and Twist Biosciences
will enable similar studies not only for respiratory viruses, but for
all types of human viral pathogens across all sample types of interest.
Darrell L. Dinwiddie, PhD Assistant Professor,
Department of Pediatrics Scholar, Clinical Translational Science
Center University of New Mexico Health Sciences Center
Add this event to your calendarMay 2, 201905/02/2019Introducing Nextera™ Flex for Enrichment Seminar
time-saving solution that is 85% faster than the standard Illumina
library prep and enrichment
Integrated DNA extraction
protocols for blood and saliva
Optimized performance using
bead-based library prep chemistry for reliable results
Compatibility with custom, fixed, or whole exome panels from
Illumina or 3rd party oligo vendors Nextera Flex for Enrichment uses a
fast, user-friendly workflow. On-bead tagmentation chemistry is
combined with a simplified, single hybridization protocol to reduce
total workflow time. From DNA input and extraction to library
normalization, enrichment, and post-enrichment amplification, the
total assay time is ~ 6.5 hours, and total hands-on time is ~2 hours.
Nextera Flex for Enrichment supports a broad DNA input range
(10-1000 ng high-quality genomic DNA or 50 ng FFPE DNA) and multiple
sample types, including blood, saliva, genomic DNA, and
formalin-fixed, paraffin-embedded (FFPE) tissue. The Flex Lysis
Reagent Kit enables fast DNA extraction from blood and saliva samples
to go directly into library prep, reducing the number of required
quantification steps to maximize cost-effectiveness. While
accommodating various study requirements, the Nextera Flex for
Enrichment solution delivers consistent insert sizes, uniform
coverage, optimized performance, and highly reproducible data across
all Illumina sequencing systems.
Location: Princess Margaret Hospital (Toronto)
Princess Margaret Hospital, Toronto, CanadaMM/DD/YYYY
Add this event to your calendarMay 1, 2019 – May 3, 201905/03/2019Frontiers in Pediatric Genomic Medicine
The annual Frontiers in Pediatric Genomic Medicine Conference brings
leaders in research, industry and healthcare together to explore
advances in translating genomic diagnostics into targeted treatment
for patients in neonatal and pediatric intensive care.
Scripps Institution of Oceanography, La Jolla, CAMM/DD/YYYY
Add this event to your calendarMay 3, 2019 – May 6, 201905/06/2019American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting 2019
Join us at the ACOG Annual Clinical and Scientific Meeting 2019 to
learn how NIPT provides safe, early, and accurate insights by
screening from a single maternal blood draw as early as 10 weeks
gestational age. Visit us at booth 1801 to learn more about the value
of NIPT in your practice.
Add this event to your calendarMay 5, 2019 – May 8, 201905/08/2019ASM Clinical Virology Conference
An annual conference hosted by the American Society for Microbiology
(ASM) covering the latest on microbiome-virome interactions, RNA
sequencing for viral diagnosis, the challenges and opportunities for a
universal influenza vaccine, and more.
Add this event to your calendarMay 14, 2019 – May 16, 201905/16/2019Vascular Discovery: From Genes to Medicine Scientific Sessions 2019
This annual meeting includes diverse disciplines within the
arteriosclerosis, thrombosis, vascular biology, peripheral vascular
disease, vascular surgery, and functional genomics research
communities that allow investigators to explore areas of
cross-disciplinary interests. In association with:
Arteriosclerosis, Thrombosis and Vascular Biology Council;
Peripheral Vascular Disease Council; Genomics & Precision
Add this event to your calendarMay 22, 2019 – May 24, 201905/24/2019Sequencing, Finishing, and Analysis in the Future Meeting
“Sequencing, Finishing and Analysis in the Future” (SFAF) is an
annual meeting dedicated to bringing together experts in the genomics
field—including representatives from the industries that serve this
specialized scientific community.
The meeting focuses on laboratory methods and computational tools
used to help sequence, assemble, and finish genomes, including new
sequencing technologies, which promise high-throughput results by
sequencing more base-pairs per run at longer read-lengths.
Add this event to your calendarMay 29, 201905/29/2019USC Translational Genomics Symposium
Please join us for a unique opportunity where we will bring together
speakers from across the academic, clinical, and biotechnology
spectrum to discuss how they are using next-generation sequencing in
this exciting space. Whether you are interested in advancing your
research, bringing game-changing therapies to market, or partnering to
maximize the effectiveness of translational studies, this event aims
to provide the research community with insights and ideas all under
the same roof.
Explore the impact of health disparities research, functional
properties of single cell, and epigenetic biomarkers and circulating
methylome snapshots to gain deeper insight into the etiology of human
disease at this symposium hosted by USC’s Keck Genomics Platform and Illumina.
In this second annual symposium, content should appeal to a wide
range of researchers seeking to apply translational genomics into
relevant clinical features.
Location: Aresty Conference Center, University of Southern
California, Los Angeles, CA
Date: Wednesday, May 29, 2019
Time: 8:00 AM - 5:00 PM PT
Aresty Conference Center, University of Southern California, Los Angeles, CAMM/DD/YYYY
Add this event to your calendarMay 30, 2019 – Jun 3, 201906/03/2019American Society of Clinical Oncology (ASCO) Annual Meeting 2019
American Society of Clinical Oncology is the world's leading
professional organization for physicians and oncology professionals
caring for people with cancer. This conference is the largest
gathering of the worldwide oncology community.
Add this event to your calendarJun 3, 2019 – Jun 6, 201906/06/2019Association of Public Health Laboratories (APHL) 2019
APHL 2019 is a four-day conference of more than 600 professionals
that addresses public health laboratory issues, trends and
technologies relative to emerging infectious disease, environmental
health, emergency preparedness, informatics, food safety, newborn
screening, global health and more. It consists of a member assembly,
plenary sessions, general and breakout sessions, roundtables, posters
and exhibits. This conference, APHL's annual membership meeting, is
open to anyone with an interest in the work of public health laboratories.
Add this event to your calendarMar 2, 2019 12:00 PMHiSeq™, NovaSeq™, and iSeq™: Project Transitions to Leverage Larger Scale Sequencing
The latest sequencing technologies enable unprecedented throughput
and redefine limits for many labs. Join Shawn Levy, Faculty
Investigator at the HudsonAlpha Institute for Biotechnology, as he
presents data demonstrating how multiple Illumina sequencing systems
can be utilized together in a lab setting to facilitate larger scale sequencing.
Add this event to your calendarMar 2, 2019 8:00 AMDelivering More Than Data: Informatics solutions for NGS with DRAGEN™ and BaseSpace™
Data volumes are growing more rapidly than ever before. Join Menzies
Chen, Illumina Product Manager, as he discusses the newest informatics
features to support high throughput, high volume sequencing. With
DRAGEN™ technology, bioinformatics workflows can now be run on
specialized hardware to accelerate the speed of analysis.
Add this event to your calendarMar 2, 2019 12:00 PMTransforming the Future of Genomics Together
Learn about the most recent product developments from Illumina in
library preparation, next-generation sequencing (NGS) systems, and
informatics. Illumina Distinguished Scientist, Gary Schroth, presents
a short overview on the newest in end to end next-generation
sequencing (NGS) solutions as well as exciting new options for the future.
Add this event to your calendarMar 1, 2019 8:00 AMLibrary Prep Innovation Pipeline at Illumina: Targeted DNA, RNA & Epigenetics
Illumina product development presents the next era of library
prep. The new Nextera™ DNA Flex and Nextera™ DNA Flex for Enrichment
library prep solutions deliver consistent insert sizes, uniform
coverage, optimized performance, and highly reproducible data across
all Illumina sequencing systems. This bead-based technology minimizes
bias and opportunities for error, resulting in highly reproducible
Add this event to your calendarFeb 28, 2019 8:00 AMDelivering New Capabilities on Illumina Sequencers, from iSeq™ to NovaSeq™
See what new product developments are available in the Illumina
sequencing portfolio. Join David Miller from Illumina Product
Marketing, as he presents data in support of new software, robust
sequencing kit performance, and longer reads on a variety of
next-generation sequencing (NGS) systems from Illumina.
Add this event to your calendarFeb 27, 2019 8:00 AMComprehensive NTRK Fusion Detection, Agnostic of the Fusion Partner, for Optimal Identification of Rare Genomic Events
NTRK fusions are rare but important recent biomarkers linked to
response to new TRK inhibitors. Comprehensive genomic profiling on all
solid tumors permits detection of rare genomic events and in the
future may enables the use of emerging treatments such as NTRK
inhibitors. NTRK genes include numerous potential fusion partners,
large intronic regions and G-C rich content, making accurate and
comprehensive detection of NTRK fusions difficult to perform in the
lab. Amongst the variable performance of NTRK fusion assays, NTRK
detection from RNA using Hybrid-Capture NGS provides comprehensive and
accurate fusion detection, agnostic of the fusion partner.
Phillip Febbo, MD Chief Medical Officer, Illumina, Inc.
Maude Champagne Clinical Oncology Marketing, Illumina, Inc.